Real-World Effectiveness and Safety of Antipsychotics in Individuals at Clinical High-Risk for Psychosis: Study Protocol for a Prospective Observational Study (ShangHai at Risk for Psychosis-Phase 2)

References

• Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70(1):107–120. doi:10.1001/jamapsychiatry.2013.26923165428
   PubMed Web of Science ®Google Scholar
• Nelson B, Yuen HP, Wood SJ, et al. Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry. 2013;70(8):793–802. doi:10.1001/jamapsychiatry.2013.127023739772
   PubMed Web of Science ®Google Scholar
• Lindstrom E, Bingefors K. Patient compliance with drug therapy in schizophrenia. Economic and clinical issues. PharmacoEconomics. 2000;18(2):106–124. doi:10.2165/00019053-200018020-0000211067646
   PubMed Web of Science ®Google Scholar
• Crumlish N, Whitty P, Clarke M, et al. Beyond the critical period: longitudinal study of 8-year outcome in first-episode non-affective psychosis. Br j Psychiatry. 2009;194(1):18–24. doi:10.1192/bjp.bp.107.04894219118320
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu L, Tang Y, et al. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome. Psychol Med. 2018;48(8):1274–1281. doi:10.1017/S003329171700270729173206
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu L, Tang Y, et al. Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery. Eur Arch Psychiatry Clin Neurosci. 2018;269:871–877.29942980
   PubMed Web of Science ®Google Scholar
• Zhang T, Cui H, Wei Y, et al. Progressive decline of cognition during the conversion from prodrome to psychosis with a characteristic pattern of the theory of mind compensated by neurocognition. Schizophr Res. 2018;195:554–559. doi:10.1016/j.schres.2017.08.02028823722
   PubMed Web of Science ®Google Scholar
• Zhang T, Cui H, Tang Y, et al. Correlation of social cognition and neurocognition on psychotic outcome: a naturalistic follow-up study of subjects with attenuated psychosis syndrome. Sci Rep. 2016;6:35017. doi:10.1038/srep3501727721394
   PubMed Web of Science ®Google Scholar
• Collin G, Seidman LJ, Keshavan MS, et al. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program. Mol Psychiatry. 2018. doi:10.1038/s41380-018-0288-x
   Web of Science ®Google Scholar
• Shakory S, Watts JJ, Hafizi S, et al. Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis. Neuropsychopharmacol. 2018;43(11):2249–2255. doi:10.1038/s41386-018-0163-0
   Web of Science ®Google Scholar
• Rauchensteiner S, Kawohl W, Ozgurdal S, et al. Test-performance after cognitive training in persons at risk mental state of schizophrenia and patients with schizophrenia. Psychiatry Res. 2011;185(3):334–339. doi:10.1016/j.psychres.2009.09.00320493540
   PubMed Web of Science ®Google Scholar
• Amminger GP, Schafer MR, Papageorgiou K, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67(2):146–154. doi:10.1001/archgenpsychiatry.2009.19220124114
   PubMed Web of Science ®Google Scholar
• McGorry PD, Nelson B, Markulev C, et al. Effect of omega-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: the NEURAPRO randomized clinical trial. JAMA Psychiatry. 2017;74(1):19–27. doi:10.1001/jamapsychiatry.2016.290227893018
   PubMed Web of Science ®Google Scholar
• McGorry PD, Yung AR, Phillips LJ, et al. Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry. 2002;59(10):921–928. doi:10.1001/archpsyc.59.10.92112365879
   PubMed Web of Science ®Google Scholar
• Zhang T, Li H, Woodberry KA, et al. Interaction of social role functioning and coping in people with recent-onset attenuated psychotic symptoms: a case study of three Chinese women at clinical high risk for psychosis. Neuropsychiatr Dis Treat. 2015;11:1647–1654. doi:10.2147/NDT26185448
   PubMed Web of Science ®Google Scholar
• Zhang T, Li H, Woodberry KA, et al. Prodromal psychosis detection in a counseling center population in China: an epidemiological and clinical study. Schizophr Res. 2014;152(2–3):391–399. doi:10.1016/j.schres.2013.11.03924387999
   PubMed Web of Science ®Google Scholar
• Zhang TH, Li HJ, Woodberry KA. et al. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion. Epidemiol Psychiatr Sci;2017 287–298. doi:10.1017/S204579601600018427056022
   PubMed Web of Science ®Google Scholar
• Zheng L, Wang J, Zhang T, Li H, Li C, Jiang K. The Chinese version of the SIPS/SOPS: a pilot study of reliability and validity. Chin Mental Health J. 2012;26(8):571–576.
   Google Scholar
• Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703–715. doi:10.1093/oxfordjournals.schbul.a00704014989408
   PubMed Web of Science ®Google Scholar
• Miller TJ, McGlashan TH, Rosen JL, et al. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry. 2002;159(5):863–865. doi:10.1176/appi.ajp.159.5.86311986145
   PubMed Web of Science ®Google Scholar
• Shi C, He Y, Cheung EF, Yu X, Chan RC. An ecologically valid performance-based social functioning assessment battery for schizophrenia. Psychiatry Res. 2013;210(3):787–793. doi:10.1016/j.psychres.2013.09.02324126188
   PubMed Web of Science ®Google Scholar
• Kern RS, Nuechterlein KH, Green MF, et al. The MATRICS consensus cognitive battery, part 2: co-norming and standardization. Am J Psychiatry. 2008;165(2):214–220. doi:10.1176/appi.ajp.2007.0701004318172018
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203–213. doi:10.1176/appi.ajp.2007.0701004218172019
   PubMed Web of Science ®Google Scholar
• McGlashan TWB, Woods S. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up. New York: Oxford University Press; 2010.
   Google Scholar
• Austin SF, Mors O, Secher RG, et al. Predictors of recovery in first episode psychosis: the OPUS cohort at 10 year follow-up. Schizophr Res. 2013;150(1):163–168. doi:10.1016/j.schres.2013.07.03123932664
   PubMed Web of Science ®Google Scholar
• Simonsen C, Faerden A, Romm KL, et al. Early clinical recovery in first-episode psychosis: symptomatic remission and its correlates at 1-year follow-up. Psychiatry Res. 2017;254:118–125. doi:10.1016/j.psychres.2017.04.05028460281
   PubMed Web of Science ®Google Scholar
• Morrison AP, French P, Stewart SL, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ. 2012;344:e2233.22491790
   PubMed Web of Science ®Google Scholar
• Bechdolf A, Wagner M, Ruhrmann S, et al. Preventing progression to first-episode psychosis in early initial prodromal states. Br j Psychiatry. 2012;200(1):22–29. doi:10.1192/bjp.bp.109.06635722075649
   PubMed Web of Science ®Google Scholar